Clinical Trial Update: Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Alrex (loteprednol etabonate) to Patanol (olopatadine) for seasonal allergic conjunctivitis has completed. Results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Conjunctivitis

Drugs mentioned

• Alrex (loteprednol etabonate)
• Patanol (olopatadine hydrochloride)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Seasonal Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2012-03-13